Invivyd, Inc. (IVVD)
Last updated: 2026-10-22 02:37:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Invivyd, Inc. (IVVD) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $0.64, with a market capitalization of $179.80M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.53 to $3.07. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$179.80M | |
$0.66 | |
$5.20 | |
$0.35 | |
$0.64 | |
5.90M | |
5.04M | |
-- | |
$3.07 | |
$0.53 | |
-- | |
-- |
Invivyd, Inc. (IVVD) Latest Closing Stock Price
Invivyd, Inc. (IVVD) last closed at $0.64 as of 2026-10-21 23:56:00, unchanged from the previous close of $0.64.
During the latest regular trading session, IVVD traded between $0.35 and $5.20, with a volume of 5.90M shares. The closing price was near the lower end and near the lower end of its 52-week range.
Invivyd, Inc. (IVVD) 7-Day Stock Price Change
Over the past seven days, Invivyd, Inc. (IVVD) moved from $0.67 to $0.64, representing a decline of 5.39% ($0.04).
The stock traded between $0.60 and $0.72 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 3.43 million shares, down versus the previous seven-day period, indicating lower trading activity.
IVVD 52-Week Price Position
Position in Range: 4.3%
IVVD is currently trading at $0.64, placing it 4.3% of the way from its 52-week low of $0.53 to its 52-week high of $3.07. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Invivyd, Inc. (IVVD)?
Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.
Invivyd, Inc. Information
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 122 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Invivyd, Inc. (IVVD) Stock on MEXC
Eligible investors can buy real shares of Invivyd, Inc. (IVVD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Invivyd, Inc. (IVVD) stock price today?
2.Is IVVD stock going up or down today?
3.What is IVVD pre-market price?
4.What is IVVD after-hours price?
5.Is IVVD stock trading now?
6.Where does IVVD sit relative to its 52-week high and low?
7.What sector is Invivyd, Inc. in?
8.What is Invivyd, Inc.'s market capitalization and where is it listed?
9.How is IVVD valued in terms of P/E ratio and EPS?
10.Does Invivyd, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
IVVD Stock Calculator
Estimate the value between IVVD shares and USD.
IVVD Shares to USD
1.00 IVVD shares = 0.637 USD
Calculations are estimates based on the latest available price and are for reference only.


